Incident cervical infections with high- and low-risk human papillomavirus (HPV) infections among mothers in the prospective Finnish Family HPV Study

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Louvanto, Karolina ^a,b   Rintala, Marjut A ^b   Syrjänen, Kari J ^b   Grénman, Seija E ^b   Syrjänen, Stina M ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; BLOOD ANALYSIS; CONDYLOMA ACUMINATUM; ETHNIC GROUP; FEMALE; FINNISH; FOLLOW UP; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN PAPILLOMAVIRUS TYPE 7; HUMAN PAPILLOMAVIRUS TYPE 70; HUMAN PAPILLOMAVIRUS TYPE 9; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; PAPANICOLAOU TEST; PREDICTION; PREGNANCY; PROSPECTIVE STUDY; RISK ASSESSMENT; SEXUAL BEHAVIOR; THIRD TRIMESTER PREGNANCY; WART VIRUS; ADOLESCENT; ALPHAPAPILLOMAVIRUS; CHI SQUARE DISTRIBUTION; CLASSIFICATION; COHORT ANALYSIS; FINLAND; GENETICS; ISOLATION AND PURIFICATION; KAPLAN MEIER METHOD; NONPARAMETRIC TEST; PAPILLOMAVIRUS INFECTION; POISSON DISTRIBUTION; PREGNANCY COMPLICATION; RISK FACTOR; UTERINE CERVIX DISEASE; VIROLOGY;

ADOLESCENT; ADULT; ALPHAPAPILLOMAVIRUS; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; FEMALE; FINLAND; GENOTYPE; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; PAPILLOMAVIRUS INFECTIONS; POISSON DISTRIBUTION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDIES; RISK FACTORS; STATISTICS, NONPARAMETRIC; UTERINE CERVICAL DISEASES;

EID: 79959339898     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-179     Document Type: Article

References (32)

1. De Villiers EM. Classification of papillomaviruses. Virology 2004, 324:17-27. 10.1016/j.virol.2004.03.033, 15183049.
2. Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJ, Meijer CJ, . International Agency for Research on Cancer Multicenter Cervical Cancer Study Group Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003, 348:518-27. 10.1056/NEJMoa021641, 12571259, International Agency for Research on Cancer Multicenter Cervical Cancer Study Group.
3. Bosch FX, Burchell AN, Schiffman M, Giuliano AR, de Sanjose S, Bruni L, Tortolero-Luna G, Kjaer SK, Muñoz N. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 2008, 26:K1-16.
4. Moscicki AB, Hills N, Shiboski S, Powell K, Jay N, Hanson E, Miller S, Clayton L, Farhat S, Broering J, Darragh T, Palefsky J. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA 2001, 285:2995-3002. 10.1001/jama.285.23.2995, 11410098.
5. Sellors JW, Karwalajtys TL, Kaczorowski J, Mahony JB, Lytwyn A, Chong S, Sparrow J, Lorincz A, . Survey of HPV in Ontario Women Group Incidence, clearance and predictors of human papillomavirus infection in women. CMAJ 2003, 168:421-5. 143547, 12591782, Survey of HPV in Ontario Women Group.
6. Syrjänen S, Shabalova I, Petrovichev N, Kozachenko V, Zakharova T, Pajanidi J, Podistov J, Chemeris G, Sozaeva L, Lipova E, Tsidaeva I, Ivanchenko O, Pshepurko A, Zakharenko S, Nerovjna R, Kljukina L, Erokhina O, Branovskaja M, Nikitina M, Grunberga V, Grunberg A, Juschenko A, Tosi P, Cintorino M, Santopietro R, Syrjänen K. Acquisition of high-risk human papillomavirus infections and pap smear abnormalities among women in the New Independent States of the Former Soviet Union. J Clin Microbiol 2004, 42:505-11. 10.1128/JCM.42.2.505-511.2004, 344495, 14766808.
7. Syrjänen S, Shabalova I, Petrovichev N, Podistov J, Ivanchenko O, Zakharenko S, Nerovjna R, Kljukina L, Branovskaja M, Juschenko A, Tosi P, Syrjänen K, . NIS Cohort Study Group Age-specific incidence and clearance of high-risk human papillomavirus infections in women in the former Soviet Union. Int J STD AIDS 2005, 16:217-23. 10.1258/0956462053420211, 15835076, NIS Cohort Study Group.
8. Franco EL, Villa LL, Sobrinho JP, Prado JM, Rousseau MC, Désy M, Rohan TE. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis 1999, 180:1415-23. 10.1086/315086, 10515798.
9. Giuliano AR, Harris R, Sedjo RL, Baldwin S, Roe D, Papenfuss MR, Abrahamsen M, Inserra P, Olvera S, Hatch K. Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study. J Infect Dis 2002, 186:462-9. 10.1086/341782, 12195372.
10. Muñoz N, Méndez F, Posso H, Molano M, van den Brule AJ, Ronderos M, Meijer C, Muñoz A, . Instituto Nacional de Cancerologia HPV Study Group Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results. J Infect Dis 2004, 190:2077-87. 10.1086/425907, 15551205, Instituto Nacional de Cancerologia HPV Study Group.
11. Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003, 157:218-26. 10.1093/aje/kwf180, 12543621.
12. Chao A, Chang CJ, Lai CH, Chao FY, Hsu YH, Chou HH, Huang HJ, Jung SM, Lin CT, Cheng HH, Huang CC, Yang JE, Chang TC. Incidence and outcome of acquisition of human papillomavirus infection in women with normal cytology--a population-based cohort study from Taiwan. Int J Cancer 2010, 126:191-8. 10.1002/ijc.24717, 19585574.
13. Nielsen A, Iftner T, Munk C, Kjaer SK. Acquisition of high-risk human papillomavirus infection in a population-based cohort of Danish women. Sex Transm Dis 2009, 36:609-15. 10.1097/OLQ.0b013e3181a96d0e, 2789348, 19955872.
14. Fukuchi E, Sawaya GF, Chirenje M, Magure T, Tuveson J, Ma Y, Shiboski S, Da Costa M, Palefsky J, Moscicki AB, Makunike-Mutasa R, Chipato T, Smith-McCune KK. Cervical human papillomavirus incidence and persistence in a cohort of HIV-negative women in Zimbabwe. Sex Transm Dis 2009, 36:305-11. 10.1097/OLQ.0b013e318194eb76, 19295468.
15. Oh JK, Ju YH, Franceschi S, Quint W, Shin HR. Acquisition of new infection and clearance of type-specific human papillomavirus infections in female students in Busan, South Korea: a follow-up study. BMC Infect Dis 2008, 8:13. 10.1186/1471-2334-8-13, 2257960, 18234114.
16. Goodman MT, Shvetsov YB, McDuffie K, Wilkens LR, Zhu X, Thompson PJ, Ning L, Killeen J, Kamemoto L, Hernandez BY. Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study. Cancer Res 2008, 68:8813-24. 10.1158/0008-5472.CAN-08-1380, 2727731, 18974124.
17. Richardson H, Kelsall G, Tellier P, Voyer H, Abrahamowicz M, Ferenczy A, Coutlée F, Franco EL. The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiol Biomarkers Prev 2003, 12:485-90.
18. Rintala MA, Grénman SE, Puranen MH, Isolauri E, Ekblad U, Kero PO, Syrjänen SM. Transmission of high risk HPV between parents and infants: a prospective HPV Family Study in Finland. J Clin Microbiol 2005, 43:376-81. 10.1128/JCM.43.1.376-381.2005, 540188, 15634997.
19. Rintala MA, Grénman SE, Järvenkylä ME, Syrjänen KJ, Syrjänen SM. High-risk types of human papillomavirus (HPV) DNA in oral and genital mucosa of infants during their first 3 years of life: experience from the Finnish HPV Family Study. Clin Infect Dis 2005, 41:1728-33. 10.1086/498114, 16288396.
20. Louvanto K, Syrjänen KJ, Rintala MA, Grénman SE, Syrjänen SM. Genotype-specific clearance of genital human papillomavirus (HPV) infections among mothers in the Finnish family HPV study. J Clin Microbiol 2010, 48:2665-71. 10.1128/JCM.00783-10, 2916623, 20554830.
21. Schmitt M, Bravo IG, Snijders PJ, Gissmann L, Pawlita M, Waterboer T. Bead-based multiplex genotyping of human papillomaviruses. J Clin Microbiol 2006, 44:504-12. 10.1128/JCM.44.2.504-512.2006, 1392679, 16455905.
22. Snijders PJF, van den Brule AJC, Schrijnemakers HFJ, Snow G, Meijer CJLM, Walboomers JMM. The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. J Gen Virol 1990, 71:173-181. 10.1099/0022-1317-71-1-173, 2154534.
23. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16:1215. 10.1093/nar/16.3.1215, 334765, 3344216.
24. Anttila M, Syrjänen S, Ji H, Saarikoski S, Syrjänen K. Failure to demonstrate human papillomavirus DNA in epithelial ovarian cancer by general primer PCR. Gynecol Oncol 1999, 72:337-341. 10.1006/gyno.1998.5264, 10053104.
25. Syrjänen S, Waterboer T, Sarkola M, Michael K, Rintala M, Syrjänen K, Grenman S, Pawlita M. Dynamics of human papillomavirus serology in women followed up for 36 months after pregnancy. J Gen Virol 2009, 90:1515-26. 10.1099/vir.0.007823-0, 19264653.
26. Diggle PJ, Liang KY, Zeger SL. Analysis of longitudinal data 1994, Oxford: Oxford University Press, 1.
27. Hardin J, Hilbe JM. Generalized estimating equations 2003, Boca Raton, FL: Chapman & Hall.
28. Kulmala SM, Shabalova IP, Petrovitchev N, Syrjänen KJ, Gyllensten UB, Johansson BC, Syrjänen SM, . New Independent States of the former Soviet Union Cohort Study Group Type-specific persistence of high-risk human papillomavirus infections in the New Independent States of the former Soviet Union Cohort Study. Cancer Epidemiol Biomarkers Prev 2007, 16:17-22. 10.1158/1055-9965.EPI-06-0649, 17220327, New Independent States of the former Soviet Union Cohort Study Group.
29. Ho GY, Studentsov YY, Bierman R, Burk RD. Natural history of human papillomavirus type 16 virus-like particle antibodies in young women. Cancer Epidemiol Biomarkers Prev 2004, 13(1):110-6. 10.1158/1055-9965.EPI-03-0191, 14744741.
30. Carter JJ, Koutsky LA, Hughes JP, Lee SK, Kuypers J, Kiviat N, Galloway DA. Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis 2000, 181(6):1911-9. 10.1086/315498, 10837170.
31. Louvanto K, Rintala M, Syrjänen K, Grenman S, Syrjänen S. Genotype-specific persistence of genital human papillomavirus (HPV) infections in women followed for 6 years in the Finnish Family HPV Study. J Infect Dis 2010, 202:436-44. 10.1086/653826, 20557239.
32. Sarkola ME, Grenman SE, Rintala MA, Syrjanen KJ, Syrjanen SM. Effect of second pregnancy on maternal carriage and outcome of high-risk human papillomavirus (HPV): experience from the prospective finnish family HPV study. Gynecol Obstet Invest 2009, 67:208-216. 10.1159/000209204, 19287178.